Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides by Breeman, Wouter A.P, Fröberg, A.C, de Blois, E, van Gameren, A, Melis, M, de Jong, M, Maina, T, Nock, B.A, Erion, J.L, Mäcke, H.R, Krenning, E.P

Get full text

Phosphoramidon enhances tumor uptake of truncated [111 In-DOTA]gastrins by Kaloudi, A, Lymperis, E, Krenning, E.P, Nock, B.A, de Jong, M, Maina, T

Get full text

Effects of Gly11 /DAla11 -replacement in GRPR-antagonist based radioligands by Lymperis, E, Maina, T, Kaloudi, A, Krenning, E.P, de Jong, M, Nock, B.A

Get full text

New GRPR-antagonists mimicking [99m Tc]Demobesin 1 by Maina, T, Nikolopoulou, A, Cescato, R, Charalambidis, D, Waser, B, Ketani, E, Reubi, J.C, Nock, B.A

Get full text

99mTc-gastrins: Impact of (Glu)5-chain and NEP-inhibition on pharmacokinetics by Kaloudi, A., Nock, B.A., Lymperis, E., Krenning, E.P., de Jong, M., Maina, T.

Get full text

99m Tc-gastrins: Impact of (Glu)5 -chain and NEP-inhibition on pharmacokinetics by Kaloudi, A, Nock, B.A, Lymperis, E, Krenning, E.P, de Jong, M, Maina, T

Get full text

567 PET imaging of therapy-naïve primary prostate cancer patients using the GRPr-targeting ligand Sarabesin 3 by Bakker, I.L, Fröberg, A.C, Busstra, M.B, Van Leenders, G.J.L.H, De Blois, E, Schoots, I, Veenland, J, Maina, T, Van Weerden, W.M, Nock, B.A, De Jong, M

Get full text

Interaction of [ReO(SNS) (S)] and [ 99mTcO(SNS) (S)] mixed ligand complexes with glutathione: isolation and characterization of the product by Pelecanou, M., Pirmettis, I.C., Nock, B.A., Papadopoulos, M., Chiotellis, E., Stassinopoulou, C.I.

Get full text

Characterization and preliminary evaluation of ester-modified technetium-99m SNS/S mixed ligand complexes as potential brain perfusion agents by Tsoukalas, C, Papadopoulos, M.S, Maina, T, Pirmettis, I.C, Nock, B.A, Raptopoulou, C, Terzis, A, Chiotellis, E

Get full text